Bonescreen is a TU Münich spin-out company enabling opportunistic disease detection” of patients CT-scan for additional diseases. bonescreen’s identified digital biomarkers combined with AI-supported analysis tools detect early stages of osteoporosis. Bonescreen enables early diagnosis and early therapeutic treatment – with higher probability of best clinical outcome for patients. We defined core tasks and addressed […]